CHATTANOOGA, TN., Advanced Catheter Therapies, Inc., today announced that its Occlusion Perfusion Catheter™ (OPC) has received its second U.S. Food and Drug Administration (FDA) 510(k) clearance. The ...

CHATTANOOGA, Tenn., Nov. 02, 2023 (GLOBE NEWSWIRE) -- The Occlusion Perfusion Catheter (OPC), a multi-lumen balloon catheter from Advanced Catheter Therapies (ACT), was recently selected by ...

Please provide your email address to receive an email when new articles are posted on . Teleflex’s percutaneous transluminal coronary angioplasty perfusion balloon catheter has received FDA 510(k) ...

Chattanooga, Tenn.-based Advanced Catheter Therapies received FDA 510(k) clearance for its Occlusion Perfusion Catheter, a multi-lumen balloon catheter on Tuesday. The medical device technology can ...

WAYNE, Pa., July 31, 2024 (GLOBE NEWSWIRE) -- Teleflex Incorporated (NYSE: TFX), a leading global provider of medical technologies, today announced U.S. Food and Drug Administration (FDA) 510(k) ...

Please provide your email address to receive an email when new articles are posted on . LAS VEGAS — The use of a catheter to deliver paclitaxel to prevent restenosis in patients with below-the-knee ...

WAYNE, Pa., March 27, 2025 (GLOBE NEWSWIRE) -- Teleflex Incorporated (TFX), a leading global provider of medical technologies, today announced that the preliminary results from its Ringer™ PBC IDE ...

We describe a novel technique to perform whole-body perfusion fixation in mice with specific relevance to micro-imaging. With the guidance of high-frequency ultrasound imaging, we were able to perfuse ...

In anesthetized pigs, a catheter was placed into the liver through the right femoral vein. Two types of catheters without and with balloon were employed, and their ability to perfuse the liver was ...

WAYNE, Pa., July 31, 2024 (GLOBE NEWSWIRE) -- Teleflex Incorporated (NYSE: TFX), a leading global provider of medical technologies, today announced U.S. Food and Drug Administration (FDA) 510(k) ...